Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2026-02-20 @ 1:44 PM
Study NCT ID:
NCT00381303
Status:
COMPLETED
Last Update Posted:
2014-04-21
First Post:
2006-09-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
Sponsor:
Tibotec, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-26
First Submit QC Date:
None
Study First Post Date:
2006-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-11-24
Results First Submit QC Date:
None
Results First Post Date:
2010-10-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-02
Last Update Post Date:
2014-04-21
Last Update Post Date Type:
ESTIMATED